Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli - Test2 - elhamkhani - TriplyDB

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli

http://www.wikidata.org/entity/Q28144457

about

Enhancing oral vaccine potency by targeting intestinal M cells Subcutaneous immunization with inactivated bacterial components and purified protein of Escherichia coli, Fusobacterium necrophorum and Trueperella pyogenes prevents puerperal metritis in Holstein dairy cows Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development Phase and antigenic variation in bacteria Type 1 fimbrial adhesin FimH elicits an immune response that enhances cell adhesion of Escherichia coli Intervening with urinary tract infections using anti-adhesives based on the crystal structure of the FimH-oligomannose-3 complex Adhesive Pili in UTI Pathogenesis and Drug Development Urinary tract infections: epidemiology, mechanisms of infection and treatment options Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection Domain activities of PapC usher reveal the mechanism of action of an Escherichia coli molecular machine.Nitazoxanide Inhibits Pilus Biogenesis by Interfering with Folding of the Usher Protein in the Outer Membrane Weak rolling adhesion enhances bacterial surface colonization.Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis P-fimbriae in the presence of anti-PapA antibodies: new insight of antibodies action against pathogens Biofilm formation in a hydrodynamic environment by novel fimh variants and ramifications for virulence.FimH forms catch bonds that are enhanced by mechanical force due to allosteric regulation.Mucosal immunization with iron receptor antigens protects against urinary tract infection.Towards a vaccine against Escherichia coli-associated urinary tract infections.FaaPred: a SVM-based prediction method for fungal adhesins and adhesin-like proteins.Waging war against uropathogenic Escherichia coli: winning back the urinary tract Metabolic Adaptations of Uropathogenic E. coli in the Urinary Tract.The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection.Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.Cellular immunity survey against urinary tract infection using pVAX/fimH cassette with mammalian and wild type codon usage as a DNA vaccine Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.Ongoing horizontal and vertical transmission of virulence genes and papA alleles among Escherichia coli blood isolates from patients with diverse-source bacteremia.A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice.Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces.Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections.A murine model of urinary tract infection.Effect of inactivation of the global oxidative stress regulator oxyR on the colonization ability of Escherichia coli O1:K1:H7 in a mouse model of ascending urinary tract infection Antigen 43-mediated autotransporter display, a versatile bacterial cell surface presentation system Novel antigens for enterotoxigenic Escherichia coli vaccines How to make it in the urinary tract: a tutorial by Escherichia coli Point mutations in FimH adhesin of Crohn's disease-associated adherent-invasive Escherichia coli enhance intestinal inflammatory response.Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine.Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells Mapping the binding domain of the F18 fimbrial adhesin.

P2860

Q21089613-38DA8FA1-4457-4D11-843C-9E3A420AE4BE Q21089713-FB627DB1-0545-4A1C-A909-C639006EF54F Q21328677-02074CC1-00D5-47EE-893B-83C1B2A5C2D9 Q24561666-A7BC42E7-3613-4300-B31E-B40F785BC305 Q24635242-A826B2DF-83DC-4DB7-AB98-B20AF900450B Q24645503-FED53A13-5A46-48AA-9674-0582D945DCAC Q26752944-3E3EA12E-1A8F-44FB-BF5F-271B7A94FB68 Q27022487-20AD6647-48C8-487E-BE11-D439B4F42BFF Q27489747-3A89E5C6-51EE-41EF-8C57-039C415B2D93 Q27728113-2D100FF1-7D7C-4D10-84B4-3C20AEEF6DA1 Q28475353-AFD3DF10-0FAD-42C4-A151-E4451DB31CCE Q30155305-FD0EFBB6-E17C-47BA-AA9E-2855A2254588 Q30277655-78CB14D7-9CC3-4FC8-817C-799AA1A4B1B8 Q30479341-7587951F-FB27-4EFC-88B4-74B9127E1978 Q30491878-DFE58C1C-2545-40F5-8DBB-03B4D3BE736C Q30558351-45E08A4B-09DB-415F-B845-314A1497E8C2 Q30652800-04C5207E-5CA8-4722-99FB-1AD63FA89CB2 Q33320807-55655901-D894-4090-A6DA-302F82DFD76A Q33508792-C8A44963-706F-41F9-8DBF-8584AF6C5C40 Q33538262-A785C0EB-46F9-4D80-9C40-1688E1525F89 Q33543109-121E7C1F-30C0-4649-8ACC-6F9F0A1B651D Q33613902-74D320AC-794B-42D5-BFDE-D2CFF886B370 Q33776967-96214DB6-6DDA-4AED-A34F-64E9932ECC45 Q33794411-80C97D0B-F7A5-435C-8228-3D69C5041BDF Q33836664-5C1BDC6A-DF98-4C81-B780-0F4C075653C1 Q33850497-77A2F24F-9DB6-4813-91A3-A27B751D8A34 Q34008358-08D9D38B-4A55-4B88-BA48-7798FFAC372D Q34008836-C66A14F7-57AA-4F31-A927-057493A00167 Q34045099-C2027403-6AA9-45E1-BE70-71915EBC80D9 Q34074980-F8204431-2DD1-49F8-A9FC-D5D8880B9931 Q34136783-61EC8E42-B661-4808-95AC-B67AA93A01B0 Q34236010-6114E73B-A147-40EF-9A04-D11DB9C32C1A Q34301248-AF42F68C-E04C-4295-9A9C-59F8896D6E6D Q34315723-32C1CF12-B5C4-4E86-8955-D3AF79DD43BA Q34349166-1DA7D220-D51E-43EB-8BF9-8F7533C8B156 Q34440629-71690576-0851-4182-A2D9-1306AEA112C7 Q34565942-93941584-31DD-4E03-812C-72D8ED1F0AE8 Q34641267-4EAC17A0-3B21-4B63-82C5-0500743FA395 Q34717658-A3B372C7-1BA9-4295-BE5C-653783A08158 Q34854361-165FFB74-64F1-4C13-8CF2-41AA98EFF68C

P2860

Vaccination with FimH adhesin protects cynomolgus monkeys from colonization and infection by uropathogenic Escherichia coli

http://www.wikidata.org/entity/Q28144457

description

2000 nî lūn-bûn

@nan

2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@ast

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@en

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@nl

type

label

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@ast

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@en

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@nl

prefLabel

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@ast

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@en

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@nl

P1433

Q28144457-68BCAADA-732F-4949-A3E2-A09547A18A01

P1476

Q28144457-CB8171DA-1B9D-426A-B146-80CA82DD6122

P2093

Q28144457-00C9BCF3-77C7-4836-9AA3-5861CF101BBA

Q28144457-1020B24B-CF49-456E-A9C7-FC4778922DA0

Q28144457-10D539DA-77B4-40D6-9435-CA7C70705694

Q28144457-157D5062-B9BF-4C1F-AB89-41BE22EE2658

Q28144457-3D065E27-C00B-45A7-AD84-72C3865E6A31

Q28144457-3EC053EA-724D-4F6C-A014-933DB084DFD9

Q28144457-528A23E5-DFF4-4174-B101-890717FB15AB

Q28144457-5290F971-FF44-4A91-ADBE-C6090D76F602

Q28144457-53CDC43A-58CE-420F-B60F-C1C3CAD12255

Q28144457-58026720-2BC1-46E3-A5D1-E83FC8CDD83D

P304

Q28144457-A766B2D0-76B9-4298-B0DA-D88A75C1AC3E

P31

Q28144457-5CFFC1D2-8506-412D-9B8F-792D6C58F771

P3181

Q28144457-DC3F4884-B8CA-4A1D-915C-27E60A649A82

P356

Q28144457-A020C289-D581-40B0-9843-39E3C2A793A3

P407

Q28144457-4999AF44-772C-4830-90C1-B044E5986F74

P433

Q28144457-0E416929-363C-4B11-A338-AAC3CEE434C8

P478

Q28144457-BDD0D2E2-E6DA-44F0-AE4E-52E181073C98

P577

Q28144457-92C264F3-CF46-4C48-9C9D-71702F8D03EE

P5875

Q28144457-6674286E-80B4-4C52-89A3-E9FAE4D52AFD

P698

Q28144457-FB36D24B-570F-42C5-B902-AFEF665E0D93

P921

Q28144457-61563519-D61E-4483-A014-CB3FAC0A8614

P3181

P356

P1433

The Journal of Infectious Diseases

P1476

Vaccination with FimH adhesin ...... uropathogenic Escherichia coli

@en

P2093

A DeFusco

http://www.w3.org/2001/XMLSchema#string

C G Auguste

http://www.w3.org/2001/XMLSchema#string

J E Burlein

http://www.w3.org/2001/XMLSchema#string

J S Pinkner

http://www.w3.org/2001/XMLSchema#string

J Winberg

http://www.w3.org/2001/XMLSchema#string

K Ishikawa

http://www.w3.org/2001/XMLSchema#string

L Guldevall

http://www.w3.org/2001/XMLSchema#string

M A Schenerman

http://www.w3.org/2001/XMLSchema#string

M Söderhäll

http://www.w3.org/2001/XMLSchema#string

R Möllby

http://www.w3.org/2001/XMLSchema#string

P304

774-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2733554

http://www.w3.org/2001/XMLSchema#string

P356

10.1086/315258

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P577

2000-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12646719

http://www.w3.org/2001/XMLSchema#string

P698

10669375

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli